Gan & Lee Pharmaceuticals has kicked off its IPO subscription exercise as it seeks to bag a total of 2.5 billion yuan ($359 million) on the Main Board of the Shanghai Stock Exchange (SSE).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
